Volume 92, Issue 1 pp. 28-29
Coronary Artery Disease

Don't worry and measure FFR

Jung-Min Ahn MD

Jung-Min Ahn MD

Department of Cardiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea

Search for more papers by this author
Seung-Jung Park MD, PhD

Corresponding Author

Seung-Jung Park MD, PhD

Department of Cardiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea

Correspondence Seung-Jung Park, MD, PhD, Heart Institute, Asan Medical Center, University of Ulsan, 388-1 Pungnap-dong, Songpa-gu, Seoul 138-736, South Korea. Email: [email protected]Search for more papers by this author
First published: 02 August 2018

KEY POINTS

  • FFR-guided PCI was associated with better clinical outcomes regarding the reduction of myocardial infarction and major adverse cardiac events.
  • The clinical benefit of FFR-guided PCI was achieved with less stents and procedural cost, without additional effects on procedural time and contrast volume.
  • Physicians should measure FFR of target stenosis prior to PCI if there is no objective evidence of myocardial ischemia.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.